STEM CELL PHARMACEUTICALS INC has a total of 12 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are HOWARD FLOREY INST OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE, AAGERUP BENGT and ISOTECHNIKA PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Unspecified technologies | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Twardzik Daniel R | 12 |
#2 | Felker Thomas S | 11 |
#3 | Paskell Stefan | 10 |
#4 | Pernet Andre | 6 |
#5 | Paskell Stefan L | 1 |
#6 | Sledziewski Andrzej | 1 |
#7 | Upshall Alan | 1 |
Publication | Filing date | Title |
---|---|---|
AU2005201473A1 | TGF-alpha polypeptides, functional fragments and methods of use therefor | |
WO03016480A2 | Tgf-$g(a) polypeptides, functional fragments and methods of use therefor | |
US2002193301A1 | TGF-alpha polypeptides, functional fragments and methods of use therefor | |
AU9464701A | Method or treatment of tumors using transforming growth factor-alpha | |
CA2380635A1 | Tgf-.alpha. polypeptides, functional fragments and methods of use therefor | |
US6486122B1 | Methods of increasing body weight in a subject by administering TGF-α |